Clinical Reference Laboratory Testing Services

The Defense Health Agency (DHA) requires a contractor to provide comprehensive, non-personal clinical reference laboratory testing services. This is a follow-on requirement to an existing contract set to expire on June 30, 2026. The scope includes approximately 6,960 specialized medical tests that the Government cannot perform in-house due to limitations in capability, capacity, or infrastructure. A critical requirement is the contractor's ability to establish and maintain a secure, bidirectional electronic interface between its commercial Laboratory Information System (LIS) and the Government's MHS Genesis electronic health record. The contractor must also comply with stringent DoD cybersecurity requirements, including NIST SP 800-171 and CMMC 2.0. The acquisition strategy involves a full and open competition for a single-award Indefinite Delivery/Indefinite Quantity (ID/IQ) contract with a firm-fixed-price task order structure. The period of performance is a five-year base ordering period with a potential five-year optional ordering period, totaling ten years. The source selection process will be Performance Price Tradeoff (PPT), where non-price factors are significantly more important than price.